Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06703_nanopub.RAyllcK_IOLoAhtmfeoFU1cufKHHlS_G9fDnUrf0BNzNk#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB06703 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06703 label "Gadobutrol [drugbank:DB06703]" assertion.
- drugbank:DB06703 seeAlso DB06703 assertion.
- drugbank:DB06703 seeAlso gadavist.html assertion.
- drugbank:DB06703 seeAlso gadavist-drug.htm assertion.
- drugbank:DB06703 identifier "drugbank:DB06703" assertion.
- drugbank:DB06703 description "Intravenous gadobutrol is a second-generation extracellular non-ionic macrocyclic GBCA (gadolinium-based contrast agent) used in magnetic resonance imaging (MRI) in adults and children older than 2 years of age. It may help visualize and detect vascular abnormalities in the blood brain barrier (BBB) and central nervous system (CNS). In patients with impaired renal function, gadolinium based contrast agents increase the risk of nephrogenic systemic fibrosis (NSF). A physician should be contacted if symptoms of NSF are encountered, such as dark or red patches on the skin; stiffness in joints; trouble moving, bending or straightening arms, hands, legs or feet; burning, itching, swelling, scaling, hardening and tightening of skin; pain in hip bones or ribs; or muscle weakness. Common adverse reactions that may be experienced include headache, nausea, feeling hot, abnormal taste, and warmth, burning or pain local to the injection site. General precautions should be taken in patients who are pregnant or breastfeeding, or who have a history of allergic reaction to contrast media, bronchial asthma or an allergic respiratory disorder." assertion.
- drugbank:DB06703 title "Gadobutrol" assertion.
- drugbank:DB06703 bio2rdf_vocabulary:identifier "DB06703" assertion.
- drugbank:DB06703 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06703 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06703" assertion.
- drugbank:DB06703 bio2rdf_vocabulary:x-identifiers.org DB06703 assertion.
- drugbank:DB06703 drugbank_vocabulary:drugbank-id "DB06703" assertion.
- drugbank:DB06703 drugbank_vocabulary:x-cas cas:138071-82-6 assertion.
- drugbank:DB06703 drugbank_vocabulary:x-atc atc:V08CA09 assertion.
- drugbank:DB06703 drugbank_vocabulary:x-chebi chebi:68841 assertion.
- drugbank:DB06703 drugbank_vocabulary:x-kegg kegg:D07420 assertion.
- drugbank:DB06703 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165958377 assertion.
- drugbank:DB06703 drugbank_vocabulary:x-wikipedia wikipedia:Gadobutrol assertion.
- drugbank:DB06703 drugbank_vocabulary:x-ndc ndc:50419-325-11 assertion.